plerixafor
| SMILES | C1CNCCN(CCCNCCNC1)Cc1ccc(cc1)CN1CCNCCCNCCNCCC1 |
| InChIKey | YIQPUIGJQJDJOS-UHFFFAOYSA-N |
Chemical properties
| Hydrogen bond acceptors | 8 |
| Hydrogen bond donors | 6 |
| Rotatable bonds | 4 |
| Molecular weight (Da) | 502.4 |
Drug properties
| Molecular type | Small molecule |
| Physiological/Surrogate | Surrogate |
| Approved drug | Yes |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| CXCR4 | CXCR4 | Human | Chemokine | A | pKi | 6.85 | 6.85 | 6.85 | Guide to Pharmacology |
| CXCR4 | CXCR4 | Human | Chemokine | A | pKi | 4.2 | 5.73 | 6.85 | ChEMBL |
| CXCR4 | CXCR4 | Human | Chemokine | A | pKi | 8.22 | 8.22 | 8.22 | Drug Central |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| CXCR4 | CXCR4 | Human | Chemokine | A | pIC50 | 6.19 | 6.19 | 6.19 | Guide to Pharmacology |
| ACKR3 | ACKR3 | Human | Chemokine | A | pEC50 | 6.85 | 6.85 | 6.85 | Guide to Pharmacology |
| CXCR4 | CXCR4 | Rat | Chemokine | A | pIC50 | 6.97 | 6.98 | 7.0 | ChEMBL |
| CXCR4 | CXCR4 | Human | Chemokine | A | pIC50 | 4.82 | 7.04 | 9.09 | ChEMBL |
| CCR2 | CCR2 | Human | Chemokine | A | pIC50 | 7.98 | 7.98 | 7.98 | Drug Central |
| CCR4 | CCR4 | Human | Chemokine | A | pIC50 | 8.21 | 8.21 | 8.21 | Drug Central |
| ACKR3 | ACKR3 | Human | Chemokine | A | pEC50 | 8.16 | 8.16 | 8.16 | Drug Central |
| CXCR4 | CXCR4 | Rat | Chemokine | A | pIC50 | 8.16 | 8.16 | 8.16 | Drug Central |
| CCR2 | CCR2 | Human | Chemokine | A | pIC50 | 10.05 | 10.23 | 10.4 | ChEMBL |